Adiponectin protects against development of metabolic disturbances in a PCOS mouse model
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Significance: Women with polycystic ovary syndrome (PCOS) have reduced fertility and increased risk of developing type 2 diabetes. Adiponectin, an adipocyte-derived hormone, together with adipocyte size, is the strongest factor associated with insulin resistance in PCOS. The potential causal relationship among adiponectin levels, infertility, and metabolic dysfunction in PCOS is, however, unknown. Exploiting mouse models, we found that adiponectin is indeed involved in PCOS-related insulin resistance, and, albeit to a much smaller extent, is also involved in the development of reproductive dysfunction. Thus, increased levels of adiponectin can prevent prepubertal androgen-induced metabolic dysfunction in dihydrotestosterone-exposed mice with PCOS-like traits. Collectively, our findings support the notion that altered adipose tissue functionality is a key mediator of metabolic dysfunction in women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · cited 1×
“High levels of circulating androgens and insulin resistance are hallmarks of PCOS and increase the risk of women with PCOS developing type 2 diabetes (25).”
BackgroundLegro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · cited 1×
“Indeed, it has been demonstrated that 30–40% of women with PCOS have impaired glucose tolerance, and as many as 10% develop diabetes by the age of 40 y (3, 4).”
BackgroundTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · cited 2×
“PCOS is one of the leading causes of poor fertility and is associated with abdominal obesity, metabolic syndrome, and an increased risk of developing type 2 diabetes (1, 2).”
Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 1×
“Furthermore, overexpression of adiponectin is associated with improved whole-body insulin sensitivity and profound positive effects within adipose tissue, such as increased mitochondrial density in adipocytes, smaller adipocyte size, and transcriptional up-regulation of factors involved in lipid storage through effici…”
BackgroundPrevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 1×
“Indeed, it has been demonstrated that 30–40% of women with PCOS have impaired glucose tolerance, and as many as 10% develop diabetes by the age of 40 y (3, 4).”
BackgroundReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
GLUT2, glucose sensing and glucose homeostasis
Thorens, B. (2015) · Diabetologia · doi:10.1007/s00125-014-3451-1 · Cited by 722 · cited 1×
“GLUT2, which is expressed at a relatively low level, is not a primary factor for glucose-stimulated insulin secretion in human beta cells, since they mainly rely on GLUT1 and GLUT3 (47).”
Background
Research works printed but not linked: 42
- A Corbould, Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: Are the molecular mechanisms distinct from type 2 diabetes? Panminerva Med 50, 279–294 (2008).
- 10.4161/adip.28731 · DOI · Paper page
- 10.1210/jc.2006-1665 · DOI · Paper page
- 10.1210/jc.2011-2377 · DOI · Paper page
- 10.1016/j.peptides.2010.02.004 · DOI
- 10.1111/j.1463-1326.2012.01626.x · DOI · Paper page
- 10.1074/jbc.M505311200 · DOI · Paper page
- 10.1016/B978-0-12-398313-8.00010-5 · DOI
- 10.1016/j.mce.2015.04.026 · DOI
- 10.1155/2013/964070 · DOI
- 10.1371/journal.pone.0080416 · DOI · Paper page
- 10.1093/molehr/gav025 · DOI
- 10.1210/en.2011-1754 · DOI · Paper page
- 10.1210/en.2007-0168 · DOI · Paper page
- 10.1016/j.fertnstert.2007.03.085 · DOI
- I Ek, P Arner, A Bergqvist, K Carlström, H Wahrenberg, Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: A possible link to insulin resistance? J Clin Endocrinol Metab 82, 1147–1153 (1997).
- 10.1016/j.steroids.2013.05.001 · DOI · Paper page
- 10.1016/0026-0495(89)90198-4 · DOI · Paper page
- 10.1055/s-2007-1009245 · DOI · Paper page
- 10.1016/j.rbmo.2009.05.003 · DOI
- 10.1152/ajpendo.90731.2008 · DOI · Paper page
- 10.1677/joe.0.1610089 · DOI
- 10.1016/S0960-0760(03)00231-0 · DOI
- 10.1073/pnas.1523236113 · DOI · Paper page
- 10.1210/en.2011-1339 · DOI
- 10.1042/BJ20141455 · DOI
- 10.1007/s11154-013-9280-6 · DOI · Paper page
- 10.1172/JCI115858 · DOI · Paper page
- 10.1007/BF00200660 · DOI
- 10.1016/S0006-291X(02)00913-0 · doi:10.1016/s0006-291x(02)00913-0
- 10.1097/00126334-200212150-00009 · DOI
- 10.1210/en.2011-1754 · DOI · Paper page
- 10.1210/en.2014-1196 · DOI · Paper page
- 10.1055/s-0034-1371090 · DOI
- 10.1095/biolreprod.115.131631 · DOI · Paper page
- 10.1210/en.2012-1693 · DOI
- 10.2337/db07-0275 · DOI · Paper page
- 10.1155/2014/957076 · DOI
- 10.1038/oby.2000.47 · DOI · Paper page
- 10.1152/ajpendo.00078.2012 · DOI
- 10.1152/ajpendo.00421.2012 · DOI · Paper page
- 10.1210/jc.2009-1908 · DOI · Paper page
Cited by
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Prenatal Androgen Exposure and Transgenerational Susceptibility to Polycystic Ovary Syndrome
Risal, S., Pei, Y., Lu, H., Manti, M., Fornes, R., Pui, H.-P., Zhao, Z., Massart, J., Ohlsson, C., Lindgren, E., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0666-1 · Cited by 356
Self-citationAnimal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Self-citationHyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
Wang, J., Wu, D., Guo, H., & Li, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116940 · Cited by 322
Metadata
- Authors
- Benrick, A., Chanclón, B., Micallef, P., Wu, Y., Hadi, L., Shelton, J. M., Stener-Victorin, E., & Wernstedt Asterholm, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2017-08-08
- Volume
- 114
- Issue
- 34
- Pages
- E7187-E7196
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2742716416
- Cited by
- 137
- References
- 20
- FWCI
- 10.27
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Vetenskapsrådet (2012-1601, 2013-7107, 2014-2775)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. https://app.cochat.ai/papers/10.1073/pnas.1708854114
- The paper
- Benrick, A., Chanclón, B., Micallef, P., Wu, Y., Hadi, L., Shelton, J. M., Stener-Victorin, E., & Wernstedt Asterholm, I. (2017). Adiponectin protects against development of metabolic disturbances in a PCOS mouse model. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1708854114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.